AbbVie subsidiary asserts patent infringement claims under Hatch-Waxman Act related to AndroGel® against Perrigo and Watson
Clients AbbVie, Inc.
Jones Day represented Unimed Pharmaceuticals, LLC, a subsidiary of AbbVie, Inc., in a consolidated Hatch-Waxman patent infringement action against Perrigo Company and Watson Laboratories, Inc., relating to the defendants' submission of Abbreviated New Drug Applications to the FDA seeking approval of generic versions of AndroGel® 1.62%, a widely-prescribed treatment for males with low testosterone levels.
Unimed Pharmaceuticals LLC et al. v. Perrigo Company et al., Civil Action No. 1-13-cv-00236 (D. Del.) (Consol.) (Judge Andrews)